{"id":5894,"date":"2015-11-16T12:53:52","date_gmt":"2015-11-16T12:53:52","guid":{"rendered":"http:\/\/canyonhealth.net\/blog\/2015\/11\/16\/genfit-could-bring-nash-liver-disease-treatment-to-market-in-2019\/"},"modified":"2015-11-16T12:53:52","modified_gmt":"2015-11-16T12:53:52","slug":"genfit-could-bring-nash-liver-disease-treatment-to-market-in-2019","status":"publish","type":"post","link":"https:\/\/stuff2host.com\/index.php\/2015\/11\/16\/genfit-could-bring-nash-liver-disease-treatment-to-market-in-2019\/","title":{"rendered":"Genfit could bring NASH liver disease treatment to market in 2019"},"content":{"rendered":"<p>French biopharmaceutical company Genfit said on Monday it is to launch a phase 3 study of its treatment for liver disease NASH by year-end as part of an accelerated approval procedure which could allow it to be brought to market in 2019. Genfit shares rose 5 pct to 42.71 euros on the news. There is currently no cure for Non-alcoholic Steatohepatitis (NASH), a degenerative liver disease caused by an excessively rich diet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>French biopharmaceutical company Genfit said on Monday it is to launch a phase 3 study of its treatment for liver disease NASH by year-end as part of an accelerated approval procedure which could allow it to be brought to market in 2019. Genfit shares rose 5 pct to 42.71 euros on the news. There is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[23,33,67,80,81,82,85],"class_list":["post-5894","post","type-post","status-publish","format-standard","hentry","category-weight-management","tag-diet","tag-hcg","tag-phentermine","tag-weight","tag-weight-clinic","tag-weight-loss","tag-weight-managenemt"],"aioseo_notices":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/posts\/5894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/comments?post=5894"}],"version-history":[{"count":0,"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/posts\/5894\/revisions"}],"wp:attachment":[{"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/media?parent=5894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/categories?post=5894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stuff2host.com\/index.php\/wp-json\/wp\/v2\/tags?post=5894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}